|
業務類別
|
Biotechnology |
|
業務概覽
|
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States. |
| 公司地址
| 41 South Rio Grande Street, Salt Lake City, UT, USA, 84101 |
| 電話號碼
| +1 385 269-0203 |
| 傳真號碼
| +1 801 821-2872 |
| 公司網頁
| https://www.recursion.com |
| 員工數量
| 600 |
| Mr. Ben R. Taylor |
Chief Financial Officer, Principal Accounting Officer and President, Recursion UK |
美元 538.68K |
25/02/2026 |
| Dr. Vicki L. Goodman, M.D. |
Chief Medical Officer |
-- |
25/03/2026 |
| Dr. Najat Khan, PhD |
Director, President and Chief Executive Officer |
美元 600.00K |
30/04/2026 |
|
|
| Dr. Robert M. Hershberg, M.D.,PhD |
Vice Chairman of the Board and Lead Independent Director |
30/04/2026 |
| Ms. Elaine D. Sun |
Independent Director |
30/04/2026 |
| Mr. Dean Y. Li, M.D.,PhD |
Independent Director |
30/04/2026 |
| Mr. Zachary Bogue, J.D. |
Independent Director |
30/04/2026 |
| Dr. Blake Borgeson, PhD |
Independent Director |
30/04/2026 |
| Mr. Zavain Dar, PhD |
Independent Director |
30/04/2026 |
| Dr. Franziska Michor, PhD |
Independent Director |
30/04/2026 |
| Dr. Najat Khan, PhD |
Director, President and Chief Executive Officer |
30/04/2026 |
| Dr. Namandje N. Bumpus, PhD |
Independent Director |
30/04/2026 |
|
|
|
|
